Considering that there is a significant downregulation of motifs starting with “C” in non‐responders (Figure 7a), we further explored the expression of DNASE1L3 in cervical cancer and its impact on chemotherapy sensitivity and tumor progression. Here, DNASE1L3 is linked to cervical carcinoma.